1. Home
  2. RCKT vs NEXA Comparison

RCKT vs NEXA Comparison

Compare RCKT & NEXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • NEXA
  • Stock Information
  • Founded
  • RCKT 1999
  • NEXA 1956
  • Country
  • RCKT United States
  • NEXA Luxembourg
  • Employees
  • RCKT N/A
  • NEXA N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • NEXA Metal Mining
  • Sector
  • RCKT Health Care
  • NEXA Basic Materials
  • Exchange
  • RCKT Nasdaq
  • NEXA Nasdaq
  • Market Cap
  • RCKT 1.1B
  • NEXA 1.2B
  • IPO Year
  • RCKT N/A
  • NEXA 2017
  • Fundamental
  • Price
  • RCKT $10.47
  • NEXA $5.43
  • Analyst Decision
  • RCKT Strong Buy
  • NEXA Sell
  • Analyst Count
  • RCKT 10
  • NEXA 5
  • Target Price
  • RCKT $48.80
  • NEXA $7.00
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • NEXA 32.1K
  • Earning Date
  • RCKT 03-04-2025
  • NEXA 02-20-2025
  • Dividend Yield
  • RCKT N/A
  • NEXA N/A
  • EPS Growth
  • RCKT N/A
  • NEXA N/A
  • EPS
  • RCKT N/A
  • NEXA N/A
  • Revenue
  • RCKT N/A
  • NEXA $2,655,440,000.00
  • Revenue This Year
  • RCKT N/A
  • NEXA $6.99
  • Revenue Next Year
  • RCKT $225,168.40
  • NEXA N/A
  • P/E Ratio
  • RCKT N/A
  • NEXA N/A
  • Revenue Growth
  • RCKT N/A
  • NEXA N/A
  • 52 Week Low
  • RCKT $9.33
  • NEXA $5.10
  • 52 Week High
  • RCKT $31.47
  • NEXA $9.61
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.20
  • NEXA 40.57
  • Support Level
  • RCKT $9.33
  • NEXA $5.10
  • Resistance Level
  • RCKT $11.09
  • NEXA $5.95
  • Average True Range (ATR)
  • RCKT 0.52
  • NEXA 0.35
  • MACD
  • RCKT 0.11
  • NEXA 0.02
  • Stochastic Oscillator
  • RCKT 53.77
  • NEXA 29.20

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

Share on Social Networks: